Cargando…
Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
Retinal vein occlusions (RVOs) constitute the second most common cause of retinal vascular disease after diabetic retinopathy, with a prevalence of between 1% and 2% in persons older than 40 years of age. Despite the existence of numerous potential therapeutic options, none is entirely satisfactory,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130914/ https://www.ncbi.nlm.nih.gov/pubmed/21750610 http://dx.doi.org/10.2147/OPTH.S13774 |